Erik L. Meredith
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 5%
- Synthetic Organic Chemistry Methods
- Asymmetric Synthesis and Catalysis
Papers in
-
- Natural product bioactivities and synthesis 3
- Signaling Pathways in Disease 2
-
- Synthetic Organic Chemistry Methods 3
- Asymmetric Synthesis and Catalysis 3
- Co-authors
- Merritt B. Andrus (8 shared papers)B. B. V. Soma Sekhar (5 shared papers)Bryon Simmons (3 shared papers)Erik J. Hicken (3 shared papers)Glenn W. Allman (1 shared paper)Paul B. Savage (1 shared paper)Chunhong Li (1 shared paper)Jing Liu (1 shared paper)
- Journals
- ACS Medicinal Chemistry Letters (4 papers)Organic Letters (4 papers)Tetrahedron Letters (4 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of the American Chemical Society (1 paper)
- Partner nations
- United StatesSwitzerlandChina
In The Last Decade
Erik L. Meredith
22 papers receiving 747 citations
Peers
Comparison fields: 5 of 79
- Toxicology 49
- Organic Chemistry 347
- Geriatrics and Gerontology 47
- Microbiology 52
- Ophthalmology 74
Countries citing papers authored by Erik L. Meredith
This map shows the geographic impact of Erik L. Meredith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik L. Meredith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik L. Meredith more than expected).
Fields of papers citing papers by Erik L. Meredith
This network shows the impact of papers produced by Erik L. Meredith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik L. Meredith. The network helps show where Erik L. Meredith may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik L. Meredith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 113 | |
| 2 | 2003 | 71 | |
| 3 | 2003 | 65 | |
| 4 | 2000 | 65 | |
| 5 | 2014 | 62 | |
| 6 | 2002 | 58 | |
| 7 | 2009 | 48 | |
| 8 | 2003 | 35 | |
| 9 | 2013 | 35 | |
| 10 | 2001 | 29 | |
| 11 | 2018 | 29 | |
| 12 | 2011 | 27 | |
| 13 | 2000 | 26 | |
| 14 | 2002 | 19 | |
| 15 | 2012 | 16 | |
| 16 | 2019 | 12 | |
| 17 | 2018 | 11 | |
| 18 | 2010 | 10 | |
| 19 | 2022 | 9 | |
| 20 | 2010 | 9 |
About Erik L. Meredith
Erik L. Meredith is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Ophthalmology and Toxicology, having authored 22 papers that have together received 760 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (5 papers), Bioactive Compounds and Antitumor Agents (4 papers), Glaucoma and retinal disorders (3 papers), Natural product bioactivities and synthesis (3 papers), Synthetic Organic Chemistry Methods (3 papers), Asymmetric Synthesis and Catalysis (3 papers), Signaling Pathways in Disease (2 papers) and Synthesis and Biological Activity (2 papers). The work is most often cited by research in Toxicology (49 citations), Organic Chemistry (347 citations), Geriatrics and Gerontology (47 citations), Microbiology (52 citations) and Ophthalmology (74 citations). Erik L. Meredith has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Merritt B. Andrus, B. B. V. Soma Sekhar, Bryon Simmons, Erik J. Hicken, Glenn W. Allman, Paul B. Savage, Chunhong Li, Jing Liu, N. Kent Dalley and Wei Ma. Their work appears in journals such as ACS Medicinal Chemistry Letters, Organic Letters, Tetrahedron Letters, Bioorganic & Medicinal Chemistry Letters and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.